Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
RNAC | Cartesian Therapeutics, Inc. | President and CEO, Director | $14.8M | Jan 2, 2024 | ||
SURF | Surface Oncology, Inc. | Director | Jun 28, 2022 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|